Rapamycin vs Metformin for Longevity: Key Differences | telos rx
Hiker with a backpack standing on a rocky ridge overlooking mountain valleys at sunrise
← Back to blog
comparison

Rapamycin vs Metformin for Longevity: Key Differences

By TelosRX Editorial Team

Rapamycin vs metformin is the longevity world's biggest drug debate. Both are FDA-approved for other uses, but animal data favor rapamycin for lifespan. Neither is approved for aging. TelosRX compares mechanisms, evidence and side effects.

Two cheap, old drugs keep showing up in longevity protocols. One came from soil bacteria on Easter Island. The other came from a medieval herb called French lilac.

Both have fans who take them "for healthspan." But they work very differently, and the evidence behind each isn't equal. Here's how they compare.

What Is Rapamycin?

Rapamycin, also called sirolimus, is an FDA-approved immunosuppressant. Doctors prescribe it to stop the immune system from rejecting a transplanted kidney. It's also approved for a rare lung disease called LAM.

For longevity, interest centers on its target: mTOR. Think of mTOR as a "build and grow" switch that reads nutrient levels. Rapamycin turns it down, which pushes cells toward cleanup and repair.

For a deeper look, see our rapamycin for longevity Q&A.

What Is Metformin?

Metformin is the most widely prescribed type 2 diabetes drug in the world. It's FDA-approved to lower blood sugar in adults and children with that condition.

It mainly reduces how much glucose your liver releases. It also nudges a cellular energy sensor called AMPK. AMPK and mTOR sit on opposite sides of the same nutrient-sensing seesaw.

Our review of metformin for longevity research covers the human data in detail.

How Do the Two Drugs Connect?

Both drugs touch the same nutrient-sensing network. That's why they're so often paired in conversation.

  • Rapamycin blocks mTOR directly. It's a strong, targeted signal.
  • Metformin raises AMPK activity, which turns mTOR down indirectly. It's a gentler, broader signal.

Each mimics parts of calorie restriction without eating less. Some researchers also note that rapamycin can raise blood sugar. Metformin lowers it, which is part of the logic behind combining them.

Rapamycin vs Metformin: Head-to-Head Comparison

Feature Rapamycin (sirolimus) Metformin
FDA-approved use Kidney transplant rejection, LAM Type 2 diabetes
Main target mTOR (growth signaling) Liver glucose output, AMPK
Approved for aging? No No
Animal lifespan data Consistent extension in mice Mixed; often no effect
Human aging trials Small, short trials (e.g., PEARL) Large trial (TAME) proposed
Typical longevity-style dosing Low dose, once weekly Daily, in diabetes-range doses
Common side effects Mouth sores, higher lipids and glucose Stomach upset, low B12
Exercise interaction Not well studied May blunt some training gains

What the Animal Research Shows

This is where the two drugs split most clearly.

A landmark 2009 study in Nature fed rapamycin to genetically diverse mice starting late in life. It extended lifespan in both males and females. Few interventions had done that when started so late.

A 2025 meta-analysis in Aging Cell pooled 911 effect sizes from 167 studies across eight vertebrate species. Rapamycin produced significant lifespan extension, comparable to dietary restriction. Metformin did not.

The authors flagged high variability and publication bias. Still, the direction was consistent for rapamycin.

What the Human Research Shows

Human data are much thinner for both drugs.

Rapamycin: The PEARL trial gave healthy adults 5 mg or 10 mg weekly, or placebo, for 48 weeks. Adverse events were similar across groups. Visceral fat didn't change. Women on 10 mg saw gains in lean tissue and less self-reported pain.

Metformin: Most data are observational, drawn from people with diabetes. Some studies suggest lower rates of age-related disease. Others find no benefit once health differences are accounted for. The proposed TAME trial aims to test metformin directly against aging outcomes.

Side Effects and Safety Compared

Both drugs have well-known safety profiles at their approved doses. Longevity-style dosing differs, so risks may differ too.

  • Rapamycin: mouth ulcers, higher cholesterol and triglycerides, higher blood sugar, slower wound healing. At transplant doses, infection risk rises.
  • Metformin: nausea, diarrhea and stomach upset, often early on. Long-term use can lower vitamin B12. A rare but serious risk is lactic acidosis.

Metformin may also blunt some benefits of exercise. Studies in older adults suggest it can reduce muscle growth from strength training. That matters if training is your main longevity tool.

Which to Consider: Rapamycin or Metformin?

There's no universal answer, and neither is approved for aging. Here's how the trade-offs tend to shake out:

  • Rapamycin has the stronger animal lifespan data. Human evidence is early and small.
  • Metformin makes more sense when blood sugar is already a problem. That's its approved lane.
  • Both are prescription drugs with real side effects. Using either off-label for longevity needs a prescriber who knows your full picture.

Some people ask about combining them. A few mouse studies have tested the pair. Human data on the combination are lacking.

Building a longevity routine? Some adults explore NAD+ support alongside sleep, training and nutrition. Learn about TelosRX NAD+ nasal spray. Compounded NAD+ is not FDA-approved, and any prescription is subject to medical approval by a licensed provider.

The Basics Still Beat Both Pills

Here's the slightly unglamorous truth. Exercise, sleep, protein intake and not smoking have far more human evidence than either drug.

Rapamycin and metformin are interesting tools. They're not shortcuts around the fundamentals. Newer areas like senolytics are also worth watching, with the same caution.

TelosRX operates as an asynchronous telehealth service. You complete an online intake, and a licensed provider reviews it without a live video call.

Frequently Asked Questions

Is rapamycin better than metformin for longevity?

In animal research, rapamycin has the stronger track record. A 2025 meta-analysis of 167 studies found rapamycin extended lifespan across vertebrates, while metformin did not. Human evidence for both is limited. Neither drug is FDA-approved for aging, so "better" depends on your health profile and a provider's judgment.

Can you take rapamycin and metformin together?

Some people in longevity circles do, and a few mouse studies have tested the pair. There's no solid human data on combining them for aging. Both can affect blood sugar and lipids. Any combination should be reviewed by a licensed provider who can monitor labs and watch for interactions.

What is rapamycin used for?

Rapamycin, or sirolimus, is FDA-approved to stop the immune system from rejecting a transplanted kidney. It's also approved for lymphangioleiomyomatosis, a rare lung disease. Low-dose, intermittent use for longevity is off-label and still being studied in small human trials like PEARL.

What are the side effects of rapamycin?

Common side effects include mouth sores, higher cholesterol and triglycerides, and higher blood sugar. Wound healing can slow. At transplant doses, infection risk rises because the immune system is suppressed. In the PEARL trial, low weekly doses had adverse event rates similar to placebo over 48 weeks.

Does metformin slow aging?

It's not proven. Observational studies in people with diabetes are mixed, and a 2025 meta-analysis found no significant lifespan extension in vertebrate animals. The proposed TAME trial is designed to test this question directly. Metformin remains FDA-approved only for type 2 diabetes.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX